Stock split history for MyMD Pharmaceuticals. Instrument Name Mymd Pharmaceuticals Inc Instrument Symbol (MYMD-Q). Instrument Exchange NASDAQ ; Previous Close ; Week High/Low ; Volume. Mymd Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. (Nasdaq: MYMD) targets first quarter for trial initiation for their oral TNF-α inhibitor treatment for rheumatoid arthritis (RA). The company's IND. As of November 10, , the registrant had 50,, shares of its Common Stock, no par value per share, outstanding. DOCUMENTS INCORPORATED BY REFERENCE.
MyMD Pharmaceuticals, Inc. (adept24.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock MyMD Pharmaceuticals. Get Daily Technical Analysis of stock MyMD Pharmaceuticals with charts and key technical data RSI, MACD, Pivot points, Moving Averages, Buy/Sell signals. The latest MyMD Pharmaceuticals stock prices, stock quotes, news, and MYMD history to help you invest and trade smarter. MyMD Pharmaceuticals Inc. (NASDAQ: MYMD). $ + (+%) K. At close: Aug 6, , 4. Historical Quotes: MyMD Pharmaceuticals, Inc. ; , , , , ; , , , , Compare MYMD With Other Stocks ; , , , , Discover real-time TNF Pharmaceuticals, Inc. Common Stock (TNFA) stock prices, quotes, historical data, news, and Insights for informed trading and. MYMD logo. MyMD Pharmaceuticals Inc. MYMD. $ + $ (%) This month. Closed: US/Eastern. ANALYTICS. We've crunched the numbers using. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July The company was founded in and is. See MYMD stock price and Buy/Sell MyMD Pharmaceuticals. Discuss news and analysts' price predictions with the investor community. In the last 3 years, MYMD stock traded as high as $ and as low as $ What are the top ETFs holding MYMD Pharmaceuticals? The top ETF exchange traded.
Buy MyMD Pharmaceuticals Shares from India at $ (0 Commission) today. Start investing in MyMD Pharmaceuticals stocks from India now with fractional. Get MyMD Pharmaceuticals Inc. (MYMD) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding. MyMD Pharmaceuticals Inc Stock Price (MYMD). MyMD Pharmaceuticals Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker MYMD. The. Get the Live stock price of MyMD Pharmaceuticals Inc (MYMD), Check its Financials, Fundamental Data, Overview, Technicals, Returns & Earnings over the years. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) experienced a relatively quiet trading session on Thursday, with its stock price barely moving throughout the day. MyMD Pharmaceuticals Inc. options quotes data for sells and puts, including Notes & Data Providers. Stocks: Real-time U.S. stock quotes reflect. MyMD Pharmaceuticals, Inc. (NasdaqCM:MYMD) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest. (Nasdaq: MYMD) targets first quarter for trial initiation for their oral TNF-α inhibitor treatment for rheumatoid arthritis (RA). The company's IND. others are buying or selling, read news, get earnings results, and compare MyMD Pharmaceuticals against related stocks people have also bought.
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age. Stock analysis for TNF Pharmaceuticals Inc (MYMD:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to. MyMD Pharmaceuticals stock news, updates & related news. Find out why MyMD Pharmaceuticals's (MYMD) news sentiment is % more negative in relation to. MYMD Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical company. The Company focuses on the development of drug products that represent a.
MYMD Pharmaceuticals - Investor Presentation - Benzinga Global Small Cap Conference